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Microarray technology has become one of the elementary tools for researchers to study the genome of
organisms. As the complexity and heterogeneity of cancer is being increasingly appreciated through
genomic analysis, cancerous classification is an emerging important trend. Significant directed random
walk is proposed as one of the cancerous classification approach which have higher sensitivity of risk
gene prediction and higher accuracy of cancer classification. In this paper, the methodology and material
used for the experiment are presented. Tuning parameter selection method and weight as parameter are
applied in proposed approach. Gene expression dataset is used as the input datasets while pathway data-
set is used to build a directed graph, as reference datasets, to complete the bias process in random walk
approach. In addition, we demonstrate that our approach can improve sensitive predictions with higher
accuracy and biological meaningful classification result. Comparison result takes place between signifi-
cant directed random walk and directed random walk to show the improvement in term of sensitivity
of prediction and accuracy of cancer classification.
 2017 The Authors. Production and hosting by Elsevier B.V. on behalf of King Saud University. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Early detection is one of the key elements in the reduction of
mortality rate among disease carriers. The accurate determination
type of cancer provides adequate early treatment and also to make
sure that the treatment is efficient. For example, early malignant
pleural mesothelioma is optimally treated by extrapleural pneu-
monectomy followed by radiochemotherapy, whereas metastatic
lung cancer is cured by chemotherapy only (Kirk, 2007). Anticancer
strategies are build based on tumor morphology (morphogenesis).
As technology grows, many researchers executed various inves-
tigations on the gene expression patterns and studied the gene
mutation (Shao et al., 2011; Fahey, 2010). Microarray has beenan experimental tool to extract functional information from the
genome (Bair, 2013). In recent years, many researchers used
microarray to profile the gene expression patterns of abnormal
and normal gene in cancer (Srivastava et al., 2014; Lin et al.,
2016). These kinds of studies shed light on obtaining bio-markers
for cancer classification. Cancer classification enable doctors to
get some insights about gene expression patterns such as gene
function and interaction between genes.
Microarray has been adopted to profile gene expression data-
sets, and, applied in cancer classification. The success rate of cancer
classification on the tools is largely dependent on data mining
(Young, 2016). This is because, among gene expression datasets,
only a part gives significant expression levels towards cancer.
Therefore, a classification tools that can identify cancerous genes
with high accuracy is needed. There are several types of cancer pre-
diction and cancer classification approach (Young, 2016; Malla,
2017).
In recent years, the random walk algorithm has been used by
several researchers (Revathy and Amalraj, 2011; Li and Li, 2012;
Petrochilos et al., 2013; Lan et al., 2016; Matteo and Random,
2017) to enable a more efficient process of cancer classification.
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ment of cancer classification accuracy (Revathy and Amalraj,
2011). Through a multi-directed graph, the Random Walk with
Restart on Multigraphs (RWRM) that was introduced by Li is able
to identify gene with higher area under curve (AUC) value (Li
and Li, 2012). Petrochilos introduced the Walktrap which is a
random-walk-based community detection algorithm to identify
biological modules predisposing to cancer growth in gene expres-
sion datasets (Petrochilos et al., 2013). Bi-random walk, proposed
by Lan in 2016, is used to identify potential miRNA environmental
factor interaction (Lan et al., 2016). In 2017, random walk with
restart probability was introduced by Matteo, has the ability to
rank cancerous gene with respect to cancer modules (Matteo and
Random, 2017).
By using directed graphs to represent the random walk, the
probability of random walk is no longer 0.5 for both, the forward
and backward step (Suki and Frey, 2017), and has instead, a bias
probability of random walk which comes from a present walker
that establishes a potential direction. When the bias is small, the
walk exhibits a positive asymptotic speed in the bias direction,
while when the bias become large, the walk starts spending huge
amounts of time in bias, and constant direction before eventually
backtracking and continuing march off to infinity (Yano, 2011).
Hence, the results for every experiment no longer fluctuates
broadly due to a more systematic use of random walk with a bias
probability.
In Codling’s research, he derived a biased telegraph equation
from different turning probabilities which, is applied based on
direction of the movement (Codling et al., 2008). A similar analogy
is extended by Zlatic´, through his research, whereby the paramet-
ric equations of motion is applied to study the features of biased
random walks versus parameter values (Zlatic et al., 2010). In
2013, Liu developed the directed random walk to great effect,
which is based off a biased type random walk (Liu et al., 2013).
Due to limitation of the algorithm, directed random walk algo-
rithm is not focusing on enhanced the sensitivity of prediction.
Besides, the accuracy of cancer classification can be further
enhanced. This model was developed to classify the cancer gene
by the implementation of a directed graph. The DRW proved to
be a success in classifying cancer genes by instigating an initial
node as well as the restart the probability when the vector drops
to a certain value. Hence, a proposed method for efficient cancer
classification is the significant directed random walk which, is
the enhancement of the directed random walk.
In this study, we considerably extend our preliminary work
(Seah et al., 2017). The restart probability parameter in directed
random walk (Revathy and Amalraj, 2011) is being studied and
improvement is being considered by expanding the initial param-
eters of the directed random walk, taking the weight of each bio-
logical pathways and their relationship with genes into account.
The sensitivity of prediction is enhanced by enhanced the bond
between two genes within the gene expression data.
The restart probability parameter is tuned in the range of
0.1–0.9 in order to justify the optimum and most suitable restart
probability for the corresponding datasets. Datasets are divided
into training and test set by K-fold cross validation. Classifier is
built and experimented to justify the results of classification. The
reliability of the classifier is proved through the accuracy of cancer
classification. With lung cancer dataset used as the benchmark
dataset, its implementation in the directed random walk is anal-
ysed (Liu et al., 2013). The results are then compared with previous
works. The contribution of this approach are lies as below:
 We test the tuning parameter selection method with more
datasets. We improve directed random walk by implementation of
weight as parameter.
 We provide the detailed analysis of the proposed significant
directed random walk through extended experiments, which
conducted with six gene expression datasets.
 We report statistically significant results by comparison with
previous work.
In Section 2, we present the datasets that used during the
experiment and the details of the methodology of proposed
approach in. In Section 3, we present the results and discussion
of cancer prediction and cancer classification. Lastly, we draw the
conclusion in Section 4.
2. Materials and methods
2.1. Experimental data
The proposed algorithm, significant directed random walk, is
tested with six different input datasets and a group of reference
datasets. The input datasets are briefly described in Section 2.1.1,
while the reference datasets are presented in Section 2.1.2.
2.1.1. Input datasets
The purpose of the experiment is to evaluate the effectiveness
of the significant directed random walk (sDRW) approach in six
publicly available gene expression datasets. These datasets are
obtained from the web-based database of National Centre for
Biotechnology Information (NCBI), Gene Expression Omnibus
(GEO). GEO database stores original submitter-supplied records
as well as curated datasets. These datasets are briefly described
as follows:
1. Lung Cancer Dataset (Landi et al., 2008): The GEO ID of the cho-
sen lung cancer dataset is GSE10072. It consists of 107 samples,
which 58 are cancer, while 49 are normal tissues samples.
These samples were collected from 20 non-smokers, 26 former
smokers and 28 current smokers. The platform to prepare the
affymetrix microarray gene expression dataset is GPL96. The
ID of the samples falls from between GSM254625 until
GSM254731.
2. Liver Cancer Dataset (Tsuchiya et al., 2010): The GEO ID of cho-
sen liver cancer dataset is GSE17856. It consists of 95 samples
but only 87 samples are chosen as sample datasets. Out of these
87 samples, 43 are cancer samples and 44 are normal samples.
These 87 samples are Hepatocellular Carcinoma tissue samples
while the remaining 8 samples are metastatic liver cancer sam-
ples. The cancer cells found in metastatic liver cancer are not
liver cells because they are migrants from other parts of the
body (Roessler et al., 2015). The platform to prepare the affyme-
trix microarray gene expression dataset is GPL6480. The ID of
samples that is used in the experiment are from GSM446165
to GSM446251.
3. Thyroid Cancer Dataset (Yu et al., 2008): The GEO ID of chosen
thyroid cancer dataset is GSE5364. This dataset consists of sev-
eral cancer types but only the thyroid cancer dataset is chosen
as the sample dataset. Out of 341 samples, 51 are related to thy-
roid dataset which are 35 cancer samples and 16 normal sam-
ples. The platform to prepare Affymetrix microarray gene
expression dataset is GPL96. The ID of thyroid samples are
between GSM121979 and GSM122029.
4. Stomach Cancer Dataset (D’Errico et al., 2009): The GEO ID of
chosen stomach cancer dataset is GSE13911. It is a dataset that
mainly focuses on Microsatellite Instability (MSI) and
Microsatellite Stable (MSS) issues which resulted DNA
1830 C.S. Seah et al. / Saudi Journal of Biological Sciences 24 (2017) 1828–1841Mismatch Repair gene, does not function normally. This dataset
consists of 38 cancer samples and 31 normal samples. It is pre-
pared with the Affymetrix Human Genome U133 plus 2.0 Array,
with platform ID of GPL570. The samples ID are between
GSM350411 and GSM350479.
5. Kidney Cancer Dataset (Dalgliesh et al., 2010): The GEO ID of
chosen kidney cancer dataset is GSE17895. It focuses on Renal
Cell Carcinoma which is also known as kidney cancer that orig-
inates in the lining of proximal convoluted tubule (small tubes
in the kidney that transport urine) (Gaur et al., 2017). It consists
of 138 cancer samples and 22 normal samples. It is prepared
with Affymetrix GeneChip Human Genome U133 Plus 2.0 Array
with platform ID of GPL9101. The samples ID are between
GSM444445 to GSM444610.
6. Breast Cancer Dataset (Pawitan et al., 2005): The GEO ID of cho-
sen breast cancer dataset is GSE1456. It was prepared on two
different Affymetrix platform, GPL96 and GPL97. The results
from GPL96 will be used as the input dataset which are 22 poor
samples and 130 good samples. Breast cancer patients who died
within 5 years are considered poor samples while those
patients that can survive more than 5 years without any addi-
tional reported events are consider as good samples. The sam-
ples ID within GPL96 are GSM107072 until GSM107231.
2.1.2. References datasets
References datasets are also known as additional datasets that
supports the experiments. In the experiment of the proposed sig-
nificant directed random walk, directed graphs are used as the ref-
erence data. These directed graphs are built from 300 pathway
datasets. Fig. 1 shows the example of pathway dataset, Leukocyte
Transendothelial Migration (KEGG PATHWAY, 2017). This directedFig. 1. Biological pathway of Leukocyte Transendgraph consists of 150 metabolic and 150 non-metabolic pathways.
The pathway datasets were obtained from Kyoto Encyclopedia of
Genes and Genomes (KEGG) Pathway Database.
KEGG pathways are converted into directed graph using Sub-
pathwayMiner package in R programming (Li et al., 2009). This
directed graph covers 4113 nodes (genes) and 40875 directed
edges. The directed edge represents the interaction between genes.
The interaction between genes can be found from the pathway
datasets. Fig. 2 shows a simple illustration of a single pathway
from a complete pathway dataset whereby the influence of a par-
ticular gene onto a corresponding gene is represented by the direc-
tion of the arrowheads. Gene A influences gene B, while gene B
influences gene C. Gene C influences both genes E and D, which,
both, influence gene F. Fig. 3 displays the illustration of the influ-
ence between genes. In graph theory, eigenvector centrality is used
to measure the influence of node in a network (Meghanathan,
2015). Fig. 4 shows the illustration of the significance of genes per-
taining to their weights. The weight of each gene is determined by
the number of corresponding genes connected. The higher the
number of corresponding gene connected, the heavier the weight
of the gene, the higher its significance. Thus, gene C is regarded
as highly significant, compared to gene A and B. Fig. 5 shows the
highlighted genes in single pathway and their weights in Table 1.
The red highlighted genes, EPAC, Rap1, ITGAL, Pyk2, Vav, RhoA
shows a simple pathway within the biological pathway, Leukocyte
Transendothelial Migration (KEGG PATHWAY, 2017). These six
genes are used to show the relationship between connection and
weight. The highest weight, 11.38365 belongs to gene, Vav, which
is activated by two different genes (ITGAL and Pyk2), as shown in
Fig. 5. A gene is important if it play the roles in being influences
by other genes (Draghici et al., 2007).othelial Migration (KEGG PATHWAY, 2017).
Fig. 2. Simple illustration of single pathway data.
Fig. 3. Simple illustration of the relationship between genes.
Fig. 4. Simple illustration of relationship of weight among genes.
Fig. 5. Highlighted genes to represent a single pathway.
Table 1
Weight of highlighted gene in Fig. 5.
Nodes EPAC Rap1 ITGAL
Weight 2.338914 8.47301 6.1441
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This section contains the approaches in constructing significant
directed random walk. In order to improve existing biased random
walk (directed random walk), directed random walk has been
studied and tested. According to Liu, in his studies (Liu et al.,
2013), the restart probability was set as 0.7. In sDRW, restart prob-
ability has been tuned with a range of 0.1–0.9. After several exper-
iments, more risk pathways have been predicted and the results of
the experiments shows improvement towards the sensitivity of
cancer prediction and accuracy of cancer classification. Another
approach in the construction of the sDRW looks to the relevance
of weight in determining the significant level towards cancerous
mutation, as was utilized by Playdon (Playdon et al., 2013). The
relationship of weight between two nearest genes in a pathway
has been used as a key parameter to differentiate the cancerous
gene and normal gene. Hence, the tuning parameter selection
and weight as parameter for algorithm performance optimization
will be implemented into the sDRW to enable result enhancement,
which are, the sensitivity of cancer prediction and accuracy of can-
cer classification.
2.2.1. Significant directed random walk (sDRW)
Significant directed randomwalk (sDRW) is an improved biased
random walk that is used in cancerous gene prediction and classi-
fication. This approach makes specific hypotheses about the pre-
dictive significance of relative gene expression by providing a
range of restart probability in different cancer datasets. Although
such approach may not represent the accuracy of every datasets,
it shows the optimum accuracy of different datasets with different
restart probabilities. The second approach in sDRW implements
weight as one of its parameter. The weight of genes is different
which is dictated by the influence by previous genes. If the gene
is influenced by many genes, represented by the direction of
arrowheads, it will have higher weight compared to the rest.
Fig. 6 illustrates the whole structure of sDRW.
2.2.1.1. Tuning parameter selection. During preliminary work, the
tuning parameter selection is used in the directed random walk
algorithm (Seah et al., 2017). Directed random walk algorithm
might excluded some informative genes in selected pathway due
to the limitation in single, constant restart probability. With only
a single, constant restart probability, the optimum results cannot
be obtained. This is because different datasets have different pat-
tern of pathways. For example, cancer datasets, A and B have dif-
ferent variety of biological pathways and these biological
pathways play an important role in determining cancerous genes.
Therefore, the tuning parameter selection is proposed in significant
directed random walk in order to find out the optimum restart
probability for the corresponding cancer datasets.
Tuning parameter selection is aimed to estimate the nearby
optimum parameter for pathway (Misman et al., 2014). It is also
used to identify an effective predictive model and cancerous clas-
sification. Therefore, tuning parameter selection can lead to better
performance of sDRW compare to DRW.
Directed random walk algorithm is using a constant restart
probability, r, also known as gamma (Liu et al., 2013). Restart prob-
ability plays an important role in determining the needs of restart-
ing the random walk process. In significant directed random walk,Pyk2 Vav RhoA
3.102989 11.38365 5.149393
Fig. 6. Flowchart of sDRW.
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2017). Restart probability is applied to estimate the probability
of the node to move into the neighbouring nodes or goes backward
to the previous nodes. With a variety of restart probabilities, the
sDRW can list all the risk pathways that are topologically impor-
tant and significant to the corresponding cancerous genes. This
can identify all the risk pathways though the processing time will
increase by 9 times due to the processing of 9 different restart
probabilities. This is because with variety of restart probabilities,
the process of random walk will increase regardless to the number
of restart probabilities.
In directed random walk algorithm, restart probability is set as
0.7. Instead of only 0.7, sDRW is using additional of eight restart
probabilities in the initial stage of experiment. The eight restart
probabilities are 0.1, 0.2, 0.3, 0.4, 0.5, 0.6, 0.8, and 0.9. Of Course,
0.7 is also used in sDRW. The significant genes within pathways
can be selected and classified with better accuracy by using differ-
ent restart probability.
The process is consisting of three main steps. Firstly, the genes
in microarray datasets are selected and grouped based on their
prior pathway information from the pathway datasets. This pro-
cess repeats for each pathway in the pathway datasets and some
genes might be excluded in the process. This is because the gene
in gene expression datasets cannot be matched or cannot be found
in pathway datasets/directed graph. The P-values of genes is calcu-
lated and the significant level of genes is differentiated according
to the P-values. The calculation process is followed by the calculat-
ing of weight, t-score, and reproducible power of pathways.
Pseudo-code of tuning parameter selection in sDRW is shown in
Fig. 7. The reproducibility of gene will determine the robustness
and significant level towards cancer. The higher the reproducibility
of genes, the more the robustness and significant level of respec-
tive gene towards cancer (Jadamba and Shin, 2014). Pathway that
contain higher significant level of gene will be predicted as risk
pathway and further evaluated by restart probabilities. With
different number of nine restart probabilities, the process ofevaluation will go through nine times and the final selected risk
pathways will vary according to the restart probabilities.
The evaluation method is evaluated by the optimum number of
risk pathways that matches with the corresponding input datasets.
For example, out of nine restart probabilities, 0.1 have the most
number of selected number of pathways in lung cancer dataset.
Hence, 0.1 is set as the default restart probability for lung cancer
dataset. Note that, different cancer dataset requires different
restart probability. If there are two restart probabilities that have
same number of selected risk pathways, further evaluation steps
will be taken. The number of significant genes will be referred to,
for this evaluation step and the highest number of risk genes
selected by the corresponding restart probability will be set as
default for the corresponding cancer dataset. For example, the
restart probability of 0.2 and 0.6 have selected three risk pathways
for stomach cancer dataset. However, with the restart probability
of 0.2, 53 significant genes are selected while, the restart probabil-
ity of 0.6 selected 72 significant genes. Hence, 0.6 will be set as the
default restart probability for stomach cancer datasets. Evaluation
method will be further enhanced based on the accuracy of
classification.
2.2.1.2. Weight as parameter. The weight of every single gene is dif-
ferent, depending on the number of other genes influencing it.
Thus, the higher the number of influence, the higher the weight
of the gene. With sDRW, weight is presented as one of the impor-
tant parameter in determining the relationship between genes
(Seah et al., 2017). sDRW had proved that weight of genes can
affect the attraction bond between genes which will lead to higher
vector (Montenegro, 2009). In sDRW, the cost of travelling from
node to node is vector. The cost can be measure by different units,
depending on the application. Directed graph is defined as weight
graph when the weight value of each gene is attached to the
correspond node.
Relationship between genes, also known as direction from gene
towards next gene is fixed by pathway datasets. Since the pathway
Fig. 7. Pseudo code of tuning parameter selection method in sDRW.
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made based on directed graph. Simple illustration of pathway is
shown in Fig. 8 with corresponding matrix in Table 2.Weight of gene is corresponding between towards and forward of
random walk. With directed graph, it is lead biasedly towards the
selected gene (Pawitan et al., 2005). Formally, sDRW is defined as
Fig. 8. Simple illustration of pathway dataset.
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 
þ rWt ð1Þ
where Wt+1 is the vector, the cost of travelling towards next gene
while r is the restart probability with a range of 0.1 until 0.9. M is
an adjacency matrix developed from the original directed graph.
As weight is one of the parameter and playing an important role
in determine the connectivity between genes. Hence, weight of
two connected genes, N1 and N2 is used as average between both
genes to obtain a stable connectivity.Wt is a vector of N node which
is transmitted from N-1 node (Seah et al., 2017).
In Fig. 5, the relationship between the gene can be written as
EPAC -> Rap1 -> ITGAL -> Pyk2 -> Vav -> RhoA. Vector of sDRWwill
be calculated based on the gene shown in Fig. 5. Initial vector, W0
of first nodes (1) is zero because it is an initial node. Hence,
W0 ¼ 0
W1 ¼ ð1 0:4Þð1Þ 2:338914þ 8:473012
 
þ 0:4ð0Þ
¼ 3:243577
W2 ¼ ð1 0:4Þð1Þ 8:47301þ 6:14412
 
þ 0:4ð3:243577Þ
¼ 4:385133þ 1:297431
¼ 5:682564
W3 ¼ ð1 0:4Þð1Þ 6:1441þ 3:1029892
 
þ 0:4ð5:682564Þ
¼ 2:774127þ 2:273026
¼ 5:047153
W4 ¼ ð1 0:4Þð1Þ 3:102989þ 11:383652
 
þ 0:4ð5:047153Þ
¼ 4:345992þ 2:018861
¼ 6:364853Table 2
Adjacency matrix of relationship of gene.
A 1 2 3 4 5
1 0 0 1 0 0
2 0 0 0 1 0
3 0 1 0 0 1
4 0 0 0 0 0
5 1 0 0 0 0W5 ¼ ð1 0:4Þð1Þ 11:38365þ 5:1493932
 
þ 0:4ð6:364853Þ
¼ 4:959913þ 2:545941
¼ 7:505854
Table 3 shows the resulted vector of sDRW after 6th walk. The
fluctuation of vector happened because the weight if gene is influ-
encing the reading. Weight plays an important role to attract the
other nodes.
If the nodes have strong connectivity between each other, hence
the vector will be higher and this vector will be contributed to the
next walk. T-test score is also used in sDRW during initial probabil-
ity, hence the magnitude of t-test score will contributed to the
weight adjustments. Therefore, the genes which have higher
weight are topologically important towards cancerous and signifi-
cantly different compare to other normal genes.
Fig. 9 shows the illustration of directed graph formation from
different pathways. Each shape indicates different biological path-
ways that topologically important to different cancers. Initially,
random walk will start from A, 1 or I. It will randomly select the
significant important genes based on the weight of the next gene.
For example, the walker will walk towards 2 from 1 during single
pathway. When pathways are combined to form directed graph,
the walker will walk randomly towards any direction that have
set in directed graph. But if B have higher weight compare to 2,
hence walker will prefer walk toward B instead of 2. With different
restart probabilities toward different input datasets, the walker
will be prevented walk with only one criteria. The walker will eval-
uate the suitable restart probability and calculate the most suitable
path for the correspond dataset.
In sDRW, tuning parameter selection and weight parameter is
combined to evaluate any possibility that might happened in order
to optimize the prediction and classification of input datasets. The
restart probabilities of 0.1 until 0.9 will be used for all input data-
sets even though there is a default optimum restart probability for
each dataset. This is because some restart probabilities had pre-
dicted different pathways as risk pathways compared to default
restart probability. And the risk pathways contained cancerous
gene as well. In order to not missing any cancerous classification,
hence, all restart probability will be used and the default restart
probability will be bold in order to show the different in terms of
number of risk pathway, number of risk gene and area under curve
for accuracy purposed.3. Results and discussion
In this section, performance of sDRW showcases two methods.
The methods are used to study the effectiveness and the perfor-
mance of sDRW, which are sensitivity of cancer prediction, and
accuracy of cancer classification.3.1. Cancer prediction
Prediction method is used to predict the risk pathways and sig-
nificant genes before classifying the genes. Gene expression data-
sets are being implemented and run on directed graph with its
weight. By going through sDRW, the walker will study the vector
and P-values of each gene from the pathway. If the pathways con-
tain genes that have P-value less than 0.05, then the pathway is
used in constructing directed graph (Štefka and Holenˇa, 2013). This
is because P-value will determine the significant towards cancer
mutation. Experiment had been run with six different input data-
sets. First, risk pathways are predicted and with these detected risk
pathways, further prediction is able to take place by figuring out
the risk genes among the risk pathways. Hence, the restart proba-
Table 3
Result of vector from first node to sixth node.
Vector, W Significant Directed Random Walk
W0 0
W1 3.243577
W2 5.682564
W3 5.047153
W4 6.364853
W5 7.505854
Fig. 9. Complex illustration of pathway dataset.
Table 4
Name of risk pathway that predicted by sDRW.
Datasets Restart
probability
Significant Directed Random Walk, sDRW
Lung 0.1 Endocytosis,
Tight junction,
Focal adhesion
0.2 Pancreatic selection,
Regulation of actin cytoskeleton
0.3 Focal adhesion
0.4 ECM-receptor interaction
0.5 Leukocyte transendothelial migration,
ECM-receptor interaction
0.6 Focal adhesion
0.7 Focal adhesion
0.8 Pancreatic secretion,
Focal adhesion
0.9 ECM-receptor interaction
Stomach 0.1 TGF-beta signaling pathway
0.2 Hedgehog signaling pathway,
Notch signaling pathway
0.3 Wnt signaling pathway,
Notch signaling pathway
0.4 Hedgehog signaling pathway,
TGF-beta signaling pathway
0.5 Notch signaling pathway,
TGF-beta signaling pathway
0.6 Regulation of actin cytoskeleton
0.7 Hedgehog signaling pathway
0.8 Alanine, aspartate and glutamate metabolism,
Shigellosis,
TGF-beta signaling pathway
0.9 TGF-beta signaling pathway
Liver 0.1 Sphingolipid metabolism
0.2 Focal adhesion,
Tight junction
0.3 Tight junction
0.4 Sphingolipid metabolism,
Glycerolipid metabolism,
Lysosome
0.5 Bacterial invasion of epithelial cells
0.6 Glycerolipid metabolism,
Bacterial invasion of epithelial cells
0.7 Focal adhesion,
Glycerolipid metabolism
0.8 Glycerolipid metabolism
0.9 Sphingolipid metabolism
Tyroid 0.1 Tight junction
0.2 Cell adhesion molecules (CAMs)
Fatty acid metabolism
0.3 Tight junctionCell adhesion molecules
(CAMs)
0.4 Fatty acid metabolism
Fc gamma R-mediated phagocytosis
0.5 Regulation of actin cytoskeleton,
Wnt signaling pathway,
Fc gamma R-mediated phagocytosis,
Fatty acid metabolism
0.6 Wnt signaling pathwayCell adhesion molecules
(CAMs)
0.7 Fatty acid metabolism
0.8 MAPK signaling pathway & Fatty acid metabolism
0.9 Focal adhesion
Kidney 0.1 Endocytosis,
Regulation of actin cytoskeleton
0.2 Regulation of actin cytoskeleton
0.3 Calcium signaling pathway,
Phosphatidylinositol signaling system
0.4 Endocytosis
0.5 Phosphatidylinositol signaling system,
Regulation of actin cytoskeleton
0.6 Protein processing in endoplasmic reticulum,
PPAR signaling pathway,
Regulation of actin cytoskeleton
0.7 Endocytosis,
Regulation of actin cytoskeleton
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as the optimum restart probability for the correspond dataset. The
sensitivity of prediction will be counted based on the number of
pathways detected by the optimum restart probability. Hence,
the optimum restart probability that predicts the most number
of pathways is the most effective regardless of the number of risk
genes detected. Table 4 shows the name of risk pathway, in differ-
ent dataset that had been predicted to be significantly towards
cancerous mutation. The detected risk pathways are used to fur-
ther extended in the prediction of significant genes.
sDRW was developed based on DRW. Comparison will be taken
to evaluate the performance and effectiveness of sDRW with its
successes towards increasing the sensitivity of prediction and
accuracy of binary classification towards gene expression dataset.
Six input datasets had applied in sDRW and DRW. Firstly, the risk
pathways that predicted by both algorithm are presented in term
of name, and number of detected pathways. Table 5 shows the
comparison of name of risk pathway that predicted by sDRW and
DRW. Six datasets had applied in the experiment and the experi-
ment had run for nine times due to different restart probabilities.
Different number of risk pathways had been predicted and there
are some restart probabilities that can identify more risk pathways
compare to the other restart probabilities. Table 6 shows the com-
parison of number of risk pathways that predicted by sDRW and
DRW with the correspond different in term of number. The table
clearly identify the improvement of sDRW with more predicted
risk pathways.
Fig. 10 presents the number of risk pathways that are detected
by sDRW and DRW against six different cancer datasets. The com-
parison between the sDRW and DRW with lung cancer dataset
shows the sDRW predicting the highest number of risk pathway,
3 against the restart probability of 0.1. The comparison between
the sDRW and DRW with stomach cancer dataset shows the sDRW
predicting the highest number of risk pathway, 3 against the
restart probability of 0.8. The comparison between the sDRW and
DRW shows liver cancer dataset with the sDRW predicting the
highest number of risk pathway, 3 against the restart probability
of 0.4. The comparison between the sDRW and DRW with thyroid(continued on next page)
Table 4 (continued)
Datasets Restart
probability
Significant Directed Random Walk, sDRW
0.8 PPAR signaling pathway
0.9 Calcium signaling pathway
Breast 0.1 Neuroactive ligand-receptor interaction
0.2 Glycerophospholipid metabolism
0.3 Neuroactive ligand-receptor interaction
0.4 Adipocytokine signaling pathway,
Fatty acid metabolism,
Jak-STAT signaling pathway
0.5 Cytokine-cytokine receptor interaction,
Fatty acid metabolism
0.6 Jak-STAT signaling pathway
0.7 Neuroactive ligand-receptor interaction
0.8 Chemokine signaling pathway
0.9 Adipocytokine signaling pathway,
Glycerophospholipid metabolism
Table 5
Name of risk pathway that predicted by sDRW and DRW.
Datasets Restart
probability
Significant Directed Random Walk
Lung 0.1 Endocytosis,
Tight junction,
Focal adhesion
0.2 Pancreatic selection,
Regulation of actin cytoskeleton
0.3 Focal adhesion
0.4 ECM-receptor interaction
0.5 Leukocyte transendothelial migra
ECM-receptor interaction
0.6 Focal adhesion
0.7 Focal adhesion
0.8 Pancreatic secretion,
Focal adhesion
0.9 ECM-receptor interaction
Stomach 0.1 TGF-beta signaling pathway
0.2 Hedgehog signaling pathway,
Notch signaling pathway
0.3 Wnt signaling pathway,
Notch signaling pathway
0.4 Hedgehog signaling pathway,
TGF-beta signaling pathway
0.5 Notch signaling pathway,
TGF-beta signaling pathway
0.6 Regulation of actin cytoskeleton
0.7 Hedgehog signaling pathway
0.8 Alanine, aspartate and glutamate
Shigellosis,
TGF-beta signaling pathway
0.9 TGF-beta signaling pathway
Liver 0.1 Sphingolipid metabolism
0.2 Focal adhesion,
Tight junction
0.3 Tight junction
0.4 Sphingolipid metabolism,
Glycerolipid metabolism,
Lysosome
0.5 Bacterial invasion of epithelial cel
0.6 Glycerolipid metabolism,
Bacterial invasion of epithelial cel
0.7 Focal adhesion,
Glycerolipid metabolism
0.8 Glycerolipid metabolism
0.9 Sphingolipid metabolism
Tyroid 0.1 Tight junction
0.2 Cell adhesion molecules (CAMs)
Fatty acid metabolism
0.3 Tight junctionCell adhesion molec
(CAMs)
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risk pathway, 4 against the restart probability of 0.5. The compar-
ison between the sDRW and DRW with kidney cancer dataset
shows the sDRW predicting the highest number of risk pathway,
3 against the restart probability of 0.6. The comparison between
the sDRW and DRWwith liver cancer dataset shows the sDRW pre-
dicting the highest number of risk pathway, 3 against the restart
probability of 0.4.
3.2. Cancer classification
Binary classification has been used to classify the genes of input
datasets into cancerous genes or normal genes (Gao et al., 2009). In
this experiment, all input datasets have been divided into test set
and training set based on 5-fold cross validation. Four-fifths of
the samples were used as training set while the remaining one-
fifth was used as test set., sDRW Directed Random Walk, DRW
Tight junction
ECM-receptor interaction
ECM-receptor interaction
ECM-receptor interaction,
Focal adhesion
tion, ECM-receptor interaction,
Focal adhesion
Leukocyte transendothelial migration
Focal adhesion
Focal adhesion
Pancreatic secretion
TGF-beta signaling pathway
Hedgehog signaling pathway
Wnt signaling pathway
Hedgehog signaling pathway,
TGF-beta signaling pathway
Notch signaling pathway
Regulation of actin cytoskeleton
Hedgehog signaling pathway
metabolism, Alanine, aspartate and glutamate metabolism,
Shigellosis
TGF-beta signaling pathway
Sphingolipid metabolism
Focal adhesion,
Sphingolipid metabolism
Sphingolipid metabolism
Sphingolipid metabolism,
Tight junction
ls Bacterial invasion of epithelial cells
ls
Glycerolipid metabolism
Focal adhesion
Sphingolipid metabolism
Glycerolipid metabolism
Cell adhesion molecules (CAMs)
Cell adhesion molecules (CAMs)
ules Tight junction,Cell adhesion molecules
(CAMs)
Table 5 (continued)
Datasets Restart
probability
Significant Directed Random Walk, sDRW Directed Random Walk, DRW
0.4 Fatty acid metabolism
Fc gamma R-mediated phagocytosis
Tight junction,
Fc gamma R-mediated phagocytosis
0.5 Regulation of actin cytoskeleton,
Wnt signaling pathway,
Fc gamma R-mediated phagocytosis,
Fatty acid metabolism
Regulation of actin cytoskeleton,
Fc gamma R-mediated phagocytosis
0.6 Wnt signaling pathwayCell adhesion molecules
(CAMs)
Wnt signaling pathway,Cell adhesion molecules
(CAMs)
0.7 Fatty acid metabolism Fatty acid metabolism
0.8 MAPK signaling pathway & Fatty acid metabolism MAPK signaling pathway
0.9 Focal adhesion Focal adhesion
Kidney 0.1 Endocytosis,
Regulation of actin cytoskeleton
Regulation of actin cytoskeleton
0.2 Regulation of actin cytoskeleton Regulation of actin cytoskeleton
0.3 Calcium signaling pathway,
Phosphatidylinositol signaling system
Regulation of actin cytoskeleton,
Phosphatidylinositol signaling system
0.4 Endocytosis Endocytosis
0.5 Phosphatidylinositol signaling system,
Regulation of actin cytoskeleton
Phosphatidylinositol signaling system,
Regulation of actin cytoskeleton
0.6 Protein processing in endoplasmic reticulum,
PPAR signaling pathway,
Regulation of actin cytoskeleton
Regulation of actin cytoskeleton
0.7 Endocytosis,
Regulation of actin cytoskeleton
Endocytosis,
Regulation of actin cytoskeleton
0.8 PPAR signaling pathway PPAR signaling pathway
0.9 Calcium signaling pathway Endocytosis
Regulation of actin cytoskeleton
Breast 0.1 Neuroactive ligand-receptor interaction Adipocytokine signaling pathway
0.2 Glycerophospholipid metabolism Glycerophospholipid metabolism
0.3 Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction
0.4 Adipocytokine signaling pathway,
Fatty acid metabolism,
Jak-STAT signaling pathway
Fatty acid metabolism
0.5 Cytokine-cytokine receptor interaction,
Fatty acid metabolism
Cytokine-cytokine receptor interaction
0.6 Jak-STAT signaling pathway Jak-STAT signaling pathway
0.7 Neuroactive ligand-receptor interaction Adipocytokine signaling pathway,
Neuroactive ligand-receptor interaction
0.8 Chemokine signaling pathway Chemokine signaling pathway
0.9 Adipocytokine signaling pathway,
Glycerophospholipid metabolism
Adipocytokine signaling pathway,
Fatty acid metabolism
Table 6
Number of risk pathway detected by sDRW and DRW.
Datasets Method Restart probabilities, r
0.1 0.2 0.3 0.4 0.5 0.6 0.7 0.8 0.9
Lung, sDRW 3 2 1 1 2 1 1 2 1
GSE10072 DRW 1 1 1 2 2 1 1 1 1
Detected Extra pathway 2 1 0 1 0 0 0 1 0
Stomach, sDRW 1 2 2 2 2 1 1 3 1
GSE13911 DRW 1 1 1 2 1 1 1 2 1
Detected Extra pathway 0 1 1 0 1 0 0 1 0
Liver, sDRW 1 2 1 3 1 2 2 1 1
GSE17856 DRW 1 2 1 2 1 1 1 1 1
Detected Extra pathway 0 0 0 1 0 1 1 0 0
Tyroid, sDRW 1 2 2 2 4 2 1 2 1
GSE5364 DRW 1 1 2 2 2 2 1 1 1
Detected Extra pathway 0 1 0 0 2 0 0 1 0
Kidney, sDRW 2 1 2 1 2 3 2 1 1
GSE17895 DRW 1 1 2 1 2 1 2 1 2
Detected Extra pathway 1 0 0 0 0 2 0 0 1
Breast, sDRW 1 1 1 3 2 1 1 1 2
GSE1456 DRW 1 1 1 1 1 1 2 1 2
Detected Extra pathway 0 0 0 2 1 0 1 0 0
*The bold r is the optimum restart probability for sDRW.
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order to select the best pathway marker set. Out of three subsets,
two were used as marker evaluation subset to build classifier
and rank the pathway marker. While the remain one subset of
training set was used as feature selection dataset for assessing
which pathway marker set produced the best classification perfor-
mance. T-test statistics of pathway activities of the two subsets had
been calculated in order to build classifier. They had been ranked
by the P-values in increasing order. Out of 300 pathways, 50 top
ranked pathways were selected as feature to build logistic regres-
sion model. Pathways were added sequentially to train the logistic
regression model. While the performance of the classifier was
measured by evaluating the area under the receiver operatingFig. 10. Comparison of number of detected risk pathways becharacteristics curve (AUC) on the feature selection dataset [39].
Two marker pathway subsets were rotated to test and the signifi-
cant pathway from the correspond subset will be kept in feature
set if the AUC is increased and more than 0.9. Process is repeated
for the top 50 pathway markers in order to optimize the perfor-
mance of classifier and obtain the best feature set.
After optimized the performance of classifier, test set is used to
evaluate the performance of classifier. Pathway marker in the
selective best feature set is used in classifier. Table 7 shows the
AUC of each dataset in different restart probabilities.
Besides, comparison of number of cancerous genes that
detected by sDRW and DRW is presented in Table 8. sDRW had
successfully predicted more significant genes compare to DRW.tween sDRW and DRW in six different cancer datasets.
Table 7
AUC of every datasets against restart probabilities from 0.1 to 0.9 in sDRW.
Datasets Restart Probabilities, r
0.1 0.2 0.3 0.4 0.5 0.6 0.7 0.8 0.9
Lung 0.9676 0.9702 0.9818 0.9764 0.9819 0.9877 0.9877 0.9582 0.9871
Stomach 0.9472 0.9749 0.9362 0.8935 0.9356 0.9642 0.9215 0.9784 0.95478
Liver 0.9469 0.9844 0.9427 0.9629 0.9428 0.9525 0.9635 0.9836 0.9684
Tyroid 0.9426 0.9579 0.9869 0.9258 0.9538 0.9125 0.9312 0.9216 0.9528
Kidney 0.9615 0.9472 0.9637 0.9578 0.9472 0.9478 0.9573 0.9268 0.9637
Breast 0.8493 0.7042 0.7296 0.9508 0.8941 0.8251 0.8466 0.9943 0.9467
Table 8
Number of cancerous gene detected by sDRW and DRW.
Datasets Method Restart Probabilities, r
0.1 0.2 0.3 0.4 0.5 0.6 0.7 0.8 0.9
Lung, sDRW 268 160 118 49 112 118 118 118 49
GSE10072 DRW 63 49 49 167 167 63 118 118 45
Increment of percentage, % 325.3968 226.5306 140.8163 70.6597 32.9341 87.3016 0 0 8.8889
Stomach, sDRW 41 53 109 65 70 108 24 89 41
GSE13911 DRW 41 24 80 65 29 108 24 48 41
Increment of percentage, % 0 120.8333 36.25 0 141.3793 0 0 85.4167 0
Liver, sDRW 21 170 61 73 40 67 136 109 21
GSE17856 DRW 21 130 21 82 40 27 109 21 109
Increment of percentage, % 0 30.7692 190.4762 10.9756 0 148.1481 24.7706 4.1905 80.7339
Tyroid, sDRW 23 29 39 33 98 52 13 76 51
GSE5364 DRW 16 16 39 43 9 52 13 63 51
Increment of percentage, % 43.75 81.25 0 23.2558 988.8889 0 0 20.6349 0
Kidney, sDRW 73 39 175 34 53 94 73 19 161
GSE17895 DRW 39 39 53 34 53 39 73 19 73
Increment of percentage, % 87.1795 0 230.1887 0 0 141.0256 0 0 120.5479
Breast, sDRW 19 12 19 44 35 21 19 23 26
GSE1456 DRW 14 12 19 9 26 21 33 23 23
Increment of percentage, % 35.7143 0 0 388.8889 34.6138 0 42.4242 0 13.0435
*The bold r is the optimum restart probability for sDRW.
Table 9
Comparison of AUC between sDRW and DRW.
Dataset Method Restart Probabilities, r
0.1 0.2 0.3 0.4 0.5 0.6 0.7 0.8 0.9
Lung, sDRW 0.9676 0.9702 0.9818 0.9764 0.9819 0.9877 0.9877 0.9582 0.9871
GSE10072 DRW 0.9636 0.9761 0.9699 0.976 0.963 0.9817 0.9764 0.9764 0.9816
Stomach, sDRW 0.9472 0.9749 0.9362 0.8935 0.9356 0.9642 0.9215 0.9784 0.95478
GSE13911 DRW 0.9362 0.9235 0.9424 0.9531 0.9235 0.9642 0.9148 0.9548 0.9642
Liver, sDRW 0.9469 0.9844 0.9427 0.9629 0.9428 0.9525 0.9635 0.9836 0.9684
GSE17856 DRW 0.9225 0.9528 0.9483 0.9468 0.9241 0.9216 0.9574 0.9748 0.9425
Tyroid, sDRW 0.9426 0.9579 0.9869 0.9258 0.9538 0.9125 0.9312 0.9216 0.9528
GSE5364 DRW 0.9461 0.9472 0.9572 0.9462 0.9136 0.8467 0.9318 0.9127 0.9424
Kidney, sDRW 0.9615 0.9472 0.9637 0.9578 0.9472 0.9478 0.9573 0.9268 0.9637
GSE17895 DRW 0.9437 0.9426 0.9259 0.9471 0.9421 0.9431 0.9841 0.9144 0.9258
Breast, sDRW 0.8493 0.7042 0.7296 0.9508 0.8941 0.8251 0.8466 0.9943 0.9467
GSE1456 DRW 0.6379 0.7821 0.6872 0.9496 0.9135 0.7258 0.5984 0.9546 0.9268
*The bold r is the optimum restart probability for sDRW.
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diction. Table 9 shows the comparison of AUC after classification
between sDRW and DRW. Comparison of AUC had proved that
sDRW are better in terms of cancer classification due to higher
accuracy.
Fig. 11 shows the number of cancerous genes that are detected
by sDRW and DRW. The optimum restart probability is chosen
based on the highest number of risk pathway, which is, detected
by that corresponding restart probability. The optimum restart
probability for lung cancer dataset is 0.1, with the highest number
of cancerous gene detection, 268. With the same restart probabil-
ity, the DRW detected 63 cancerous genes, which is less than
sDRW, at about 205 genes. The optimum restart probability forstomach cancer dataset is 0.8, with the highest number of cancer-
ous gene detection, 89. With the same restart probability, the DRW
detected 48 cancerous genes, which is less than sDRW, by approx-
imately 41 genes. Even though restart probability 0.3 has detected
more genes compare to the other restart probabilities, the detected
pathways at the corresponding restart probabilities are only 2.
Hence, it will not be set as the default restart probability. The opti-
mum restart probability for liver cancer dataset is 0.4, with the
highest number of cancerous gene detection, 82. With the same
restart probability, the sDRW detected 73 cancerous genes, which
is less than DRW, by about 9 genes. Overall, restart probability 0.2
detected more genes but only detected two pathways. Compared
to lesser number of detected genes, restart probability 0.4 shows
Fig. 11. Comparison number of detected significant genes between sDRW and DRW in 8 different cancer datasets.
1840 C.S. Seah et al. / Saudi Journal of Biological Sciences 24 (2017) 1828–1841its significance by detecting more pathways. The optimum restart
probability for thyroid cancer dataset is 0.5, with the highest num-
ber of cancerous gene detection, 98. With the same restart proba-
bility, the DRW detected 9 cancerous genes, which is less than
sDRW, by about 89 genes. The optimum restart probability for kid-
ney cancer dataset is 0.6, with the highest number of cancerous
gene detection, 94. With the same restart probability, the DRW
detected 39 cancerous genes, which is less than sDRW, by about
55 genes. The optimum restart probability for breast cancer dataset
is 0.4, with the highest number of cancerous gene detection, 44.
With the same restart probability, the DRW detected 9 cancerous
genes, which is less than sDRW, by about 35 genes.
From the experiments, we concluded that the sDRW is less
effective on liver cancer dataset, which detects 9 genes less com-
pared to DRW. Overall, sDRW is more effective in proving the sen-
sitivity of the risk gene prediction.4. Conclusion
In this paper, we proposed a significant directed random walk
approach based on tuning parameter selection and weight as
parameter for cancer classification using gene expression datasets.
This approach is used as cancer classification which studied the
relationship of gene expression data and cancerous gene. The main
objective of this paper is to prove the effectiveness and perfor-
mance of the proposed approach against directed random walk.
The comparison between these two algorithms is done by compar-
ing the sensitivity of cancer prediction and accuracy of cancer clas-
sification. Throughout the experiment results, this approach had
proved to have higher sensitivity of cancerous prediction and more
accurate cancer classification.
First, tuning parameter selection is used to highlight the opti-
mum restart probability for correspond dataset by testing with
C.S. Seah et al. / Saudi Journal of Biological Sciences 24 (2017) 1828–1841 1841all nine restart probabilities. Then, the optimum restart probability
will be chosen based on the most detected number of pathways.
This is because only a complete biological pathway will generate
protein, and with more biological pathway, more genes can be
detected. Then weight among genes will be added into the path-
way while walker is working on the directed graph for cancer pre-
diction. The connectivity among gene plays an important role in
determining the vector which will determine the walker to walk
along the pathway. Finally, five-fold cross validation is used to
train the classifier and classify the significant gene that detected
by sDRW. The results demonstrated that the proposed approach
is more effective, and feasible, for cancer classification compared
to directed random walk.
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